Christopher Martell - Net Worth and Insider Trading
Christopher Martell Net Worth
The estimated net worth of Christopher Martell is at least $1 Million dollars as of 2024-09-20. Christopher Martell is the Director of Candel Therapeutics Inc and owns about 152,000 shares of Candel Therapeutics Inc (CADL) stock worth over $1 Million. Details can be seen in Christopher Martell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Martell has not made any transactions after 2022-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Martell
Christopher Martell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Martell owns 1 companies in total, including Candel Therapeutics Inc (CADL) .
Click here to see the complete history of Christopher Martell’s form 4 insider trades.
Insider Ownership Summary of Christopher Martell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2022-12-09 | director |
Christopher Martell Latest Holdings Summary
Christopher Martell currently owns a total of 1 stock. Christopher Martell owns 152,000 shares of Candel Therapeutics Inc (CADL) as of December 9, 2022, with a value of $1 Million.
Latest Holdings of Christopher Martell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CADL | Candel Therapeutics Inc | 2022-12-09 | 152,000 | 7.69 | 1,168,880 |
Holding Weightings of Christopher Martell
Christopher Martell Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Martell has made a total of 3 transactions in Candel Therapeutics Inc (CADL) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Candel Therapeutics Inc is the acquisition of 27,000 shares on December 9, 2022, which cost Christopher Martell around $51,030.
Insider Trading History of Christopher Martell
- 1
Christopher Martell Trading Performance
GuruFocus tracks the stock performance after each of Christopher Martell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Martell is 7.1%. GuruFocus also compares Christopher Martell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Martell within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Martell's insider trading performs compared to the benchmark.
Performance of Christopher Martell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.31 | | | | | |
| Relative Return to S&P 500(%) | -0.28 | | | | | |
Christopher Martell Ownership Network
Christopher Martell Owned Company Details
What does Candel Therapeutics Inc do?
Who are the key executives at Candel Therapeutics Inc?
Christopher Martell is the director of Candel Therapeutics Inc. Other key executives at Candel Therapeutics Inc include Chief Medical Officer William Garrett Nichols , See Remarks Seshu Tyagarajan , and Chief Scientific Officer Francesca Barone .
Candel Therapeutics Inc (CADL) Insider Trades Summary
Over the past 18 months, Christopher Martell made no insider transaction in Candel Therapeutics Inc (CADL). Other recent insider transactions involving Candel Therapeutics Inc (CADL) include a net sale of 42,821 shares made by Paul Peter Tak , a net sale of 28,181 shares made by Seshu Tyagarajan , and a net sale of 26,696 shares made by Francesca Barone .
In summary, during the past 3 months, insiders sold 137,123 shares of Candel Therapeutics Inc (CADL) in total and bought 0 shares, with a net sale of 137,123 shares. During the past 18 months, 137,123 shares of Candel Therapeutics Inc (CADL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 137,123 shares.
Candel Therapeutics Inc (CADL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Candel Therapeutics Inc Insider Transactions
Christopher Martell Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Martell. You might contact Christopher Martell via mailing address: Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham Ma 02494.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
